GC Therapeutics, Inc. (GCTx), announced its launch today to scale and unlock the next generation of cell therapy. Invented and developed by a world-class team of scientists in the lab of professor ...

AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an updated analysis of ...

Sorrento Therapeutics faced a financial and legal crisis in February 2023, and needed to file for bankruptcy. The pharmaceutical developer’s chief executive and chief financial officers met with ...

Viking Therapeutics' VK2735, a dual GLP-1/GIP receptor agonist, shows promising results in Phase II trials for obesity treatment with potential for both subcutaneous and oral formulations.

Travere Therapeutics (TVTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Liisa Bayko from Evercore ISI maintained a Buy rating on the ...

We came across a bullish thesis on TG Therapeutics Inc (TGTX) on ValueInvestorsClub by Bohr. In this article we will summarize the bulls' thesis on TGTX. TG Therapeutics shares were trading at $14 ...

TG Therapeutics' Briumvi shows strong revenue growth, with Q2 2024 revenue up 350% YoY, leading to an upgraded full-year guidance of $290-$300 million. Expansion into CAR-T therapy for autoimmune ...

FORT JOHNSON, La. — The US Army is gearing up its fifth Project Convergence iteration where soldiers will test out the service’s future command and control (C2) architecture to see if it’s ...